We are live on
!
Find out more
TC
TFS Capital Portfolio holdings
AUM
$255M
1-Year Est. Return
32.31%
This Fund
S&P 500
This Quarter
Est. Return
-0.66%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$694M
AUM Growth
-$235M
(-25%)
Cap. Flow
-$209M
Cap. Flow
% of AUM
-30.05%
Top 10 Holdings %
Top 10 Hldgs %
4.41%
Holding
1,236
New
502
Increased
176
Reduced
298
Closed
257
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INFI
Infinity Pharmaceuticals, Inc.
INFI
|
+$2.36M |
| 2 |
Collegium Pharmaceutical
COLL
|
+$2.32M |
| 3 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$2.29M |
| 4 |
HSII
Heidrick & Struggles
HSII
|
+$2.25M |
| 5 |
HTCH
HUTCHINSON TECHNOLOGY INC
HTCH
|
+$2.17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emergent Biosolutions
EBS
|
+$5.99M |
| 2 |
Commercial Metals
CMC
|
+$5.95M |
| 3 |
Benchmark Electronics
BHE
|
+$5.84M |
| 4 |
Upbound Group
UPBD
|
+$5.71M |
| 5 |
FreightCar America
RAIL
|
+$5.51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.04% |
| 2 | Industrials | 15.17% |
| 3 | Technology | 12.86% |
| 4 | Consumer Discretionary | 12.11% |
| 5 | Financials | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCAI
301
DELISTED
Surgical Care Affiliates, Inc.
SCAI
| $840K | 0.12% |
18,152
-18,486
| -50% | -$774K |
|
302
QuinStreet
QNST
$888M
| $839K | 0.12% |
245,335
+3,426
| +1% | +$11.6K |
|
303
Qualys
QLYS
$4.89B
| $837K | 0.12% |
+33,052
| New | +$857K |
|
304
Chemours
CC
$2.59B
| $836K | 0.12% |
119,411
+108,589
| +1,003% | +$546K |
|
305
Utah Medical Products
UTMD
$217M
| $835K | 0.12% |
+13,351
| New | +$787K |
|
|
BBRG
306
DELISTED
Bravo Brio Restaurant Group Inc.
BBRG
| $835K | 0.12% |
107,697
-97,116
| -47% | -$789K |
|
307
OraSure Technologies
OSUR
$284M
| $829K | 0.12% |
114,630
-638,439
| -85% | -$4.06M |
|
308
Consolidated Water Co
CWCO
$470M
| $823K | 0.12% |
+67,632
| New | +$760K |
|
309
J&J Snack Foods
JJSF
$1.44B
| $819K | 0.12% |
+7,563
| New | +$816K |
|
|
MGI
310
DELISTED
MoneyGram International, Inc. New
MGI
| $817K | 0.12% |
133,496
+70,792
| +113% | +$400K |
|
|
VRNT
311
DELISTED
Verint Systems
VRNT
| $811K | 0.12% |
47,709
+13,971
| +41% | +$255K |
|
|
BLD
312
DELISTED
TopBuild
BLD
| $809K | 0.12% |
+27,196
| New | +$735K |
|
|
NWHM
313
DELISTED
THE NEW HOME COMPANY INC.
NWHM
| $808K | 0.12% |
+65,917
| New | +$664K |
|
|
PKD
314
DELISTED
Parker Drilling Company
PKD
| $803K | 0.12% |
25,261
+11,726
| +87% | +$278K |
|
|
PNX
315
DELISTED
PHOENIX COMPANIES INC. NEW
PNX
| $797K | 0.11% |
+21,627
| New | +$792K |
|
|
VCRA
316
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $796K | 0.11% |
62,417
-122,063
| -66% | -$1.69M |
|
|
NTUS
317
DELISTED
Natus Medical Inc
NTUS
| $795K | 0.11% |
20,688
-17,229
| -45% | -$642K |
|
|
HF
318
DELISTED
HFF Inc.
HF
| $787K | 0.11% |
+28,584
| New | +$760K |
|
319
Neogen
NEOG
$2.08B
| $786K | 0.11% |
+41,632
| New | +$793K |
|
320
Wolverine World Wide
WWW
$1.57B
| $784K | 0.11% |
42,585
-56,301
| -57% | -$981K |
|
321
National Healthcare
NHC
$3.58B
| $783K | 0.11% |
+12,570
| New | +$783K |
|
|
MFLX
322
DELISTED
MULTI-FINELINE ELECTRONIX INC
MFLX
| $781K | 0.11% |
33,666
-78,983
| -70% | -$1.58M |
|
323
Sierra Bancorp
BSRR
$530M
| $778K | 0.11% |
+42,849
| New | +$766K |
|
|
TVTY
324
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $777K | 0.11% |
77,045
+47,559
| +161% | +$534K |
|
325
Biglari Holdings Class B
BH
$1.21B
| $775K | 0.11% |
+3,128
| New | +$755K |
|
Similar funds
KC
IPC
ECPI
FRM
WFG
IFB
KL
RP
TFS Capital's Q1 2016 Portfolio in Review
As of Q1 2016, TFS Capital held 1,236 positions worth $694M, down 25% from $929M the previous quarter. Its ten largest holdings account for 4.4% of the portfolio.
TFS Capital withdrew a net $209M in Q1 2016, closing 257 positions and reducing 298 holdings. Its most notable exit was Benchmark Electronics, an estimated $5.84M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 22% a quarter earlier, followed by Industrials and Technology.
Against the trend, TFS Capital opened a new position in Collegium Pharmaceutical worth $2.31M.
- TFS Capital's largest Q1 2016 buy was Collegium Pharmaceutical: 127,568 shares worth $2.31M.
- TFS Capital added most to Infinity Pharmaceuticals, Inc. in Q1 2016, an estimated $2.36M increase.
- TFS Capital's biggest Q1 2016 reduction was Emergent Biosolutions, cutting an estimated $5.99M.
- TFS Capital fully exited Benchmark Electronics in Q1 2016, selling an estimated $5.84M.
- TFS Capital's ten largest holdings make up 4.4% of its $694M portfolio in Q1 2016.
- TFS Capital opened 502 new positions and closed 257 in Q1 2016.
- TFS Capital's portfolio value fell 25% quarter-over-quarter to $694M.
Based on TFS Capital's 13F filing for Q1 2016, filed 10 May 2016.